

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 5.40715500 |
| 2 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.23557218 |
| 3 | sarcomere organization (GO:0045214) | 5.03143232 |
| 4 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.85315054 |
| 5 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.76892420 |
| 6 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.72648773 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.59132313 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.58310196 |
| 9 | myofibril assembly (GO:0030239) | 4.47666233 |
| 10 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.37584271 |
| 11 | cardiac muscle hypertrophy (GO:0003300) | 4.35341319 |
| 12 | cell communication by electrical coupling (GO:0010644) | 4.30255404 |
| 13 | cell communication involved in cardiac conduction (GO:0086065) | 4.17024978 |
| 14 | cardiac muscle contraction (GO:0060048) | 4.12152440 |
| 15 | striated muscle hypertrophy (GO:0014897) | 4.11189655 |
| 16 | regulation of sarcomere organization (GO:0060297) | 4.08127603 |
| 17 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.03795350 |
| 18 | detection of calcium ion (GO:0005513) | 3.91366967 |
| 19 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.75418612 |
| 20 | regulation of actin filament-based movement (GO:1903115) | 3.74934812 |
| 21 | regulation of membrane repolarization (GO:0060306) | 3.72050574 |
| 22 | cardiac muscle cell development (GO:0055013) | 3.67853326 |
| 23 | actomyosin structure organization (GO:0031032) | 3.55562499 |
| 24 | positive regulation of action potential (GO:0045760) | 3.53432612 |
| 25 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.53257089 |
| 26 | muscle hypertrophy (GO:0014896) | 3.52593024 |
| 27 | regulation of cardioblast differentiation (GO:0051890) | 3.51249227 |
| 28 | cardiac cell development (GO:0055006) | 3.46990220 |
| 29 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.44756943 |
| 30 | actin-myosin filament sliding (GO:0033275) | 3.44543263 |
| 31 | muscle filament sliding (GO:0030049) | 3.44543263 |
| 32 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.42786227 |
| 33 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.38537499 |
| 34 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.37086814 |
| 35 | relaxation of cardiac muscle (GO:0055119) | 3.37013912 |
| 36 | cardiac conduction (GO:0061337) | 3.36409898 |
| 37 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.35802052 |
| 38 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.34588094 |
| 39 | muscle hypertrophy in response to stress (GO:0003299) | 3.34588094 |
| 40 | cardiac muscle adaptation (GO:0014887) | 3.34588094 |
| 41 | adult heart development (GO:0007512) | 3.34445169 |
| 42 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.31219938 |
| 43 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.31139899 |
| 44 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.30096653 |
| 45 | plasma membrane repair (GO:0001778) | 3.30045168 |
| 46 | regulation of cell communication by electrical coupling (GO:0010649) | 3.29555912 |
| 47 | regulation of striated muscle contraction (GO:0006942) | 3.25475910 |
| 48 | heart trabecula formation (GO:0060347) | 3.22489948 |
| 49 | cardiac muscle cell action potential (GO:0086001) | 3.20673746 |
| 50 | regulation of relaxation of muscle (GO:1901077) | 3.20624637 |
| 51 | atrial septum morphogenesis (GO:0060413) | 3.16929564 |
| 52 | regulation of the force of heart contraction (GO:0002026) | 3.16212519 |
| 53 | regulation of cardiac muscle contraction (GO:0055117) | 3.16110283 |
| 54 | muscle tissue morphogenesis (GO:0060415) | 3.15731923 |
| 55 | cardiac chamber formation (GO:0003207) | 3.14756855 |
| 56 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.14755208 |
| 57 | actin-mediated cell contraction (GO:0070252) | 3.11597124 |
| 58 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.08378411 |
| 59 | striated muscle contraction (GO:0006941) | 3.06330783 |
| 60 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.06145552 |
| 61 | regulation of ATPase activity (GO:0043462) | 3.00961405 |
| 62 | regulation of ATP catabolic process (GO:1903289) | 3.00961405 |
| 63 | regulation of heart rate (GO:0002027) | 2.98762754 |
| 64 | response to epinephrine (GO:0071871) | 2.98638697 |
| 65 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.95611562 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 2.94165584 |
| 67 | membrane repolarization during action potential (GO:0086011) | 2.92984657 |
| 68 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90846934 |
| 69 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89738411 |
| 70 | response to inactivity (GO:0014854) | 2.89199945 |
| 71 | positive regulation of sodium ion transport (GO:0010765) | 2.88433142 |
| 72 | regulation of skeletal muscle contraction (GO:0014819) | 2.86542551 |
| 73 | negative regulation of protein localization to cell surface (GO:2000009) | 2.84799413 |
| 74 | carnitine shuttle (GO:0006853) | 2.84116742 |
| 75 | positive regulation of heart rate (GO:0010460) | 2.83165148 |
| 76 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.77818416 |
| 77 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.77028852 |
| 78 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.77028852 |
| 79 | negative regulation of heart rate (GO:0010459) | 2.76190052 |
| 80 | nucleobase catabolic process (GO:0046113) | 2.75895827 |
| 81 | regulation of heart contraction (GO:0008016) | 2.73933076 |
| 82 | negative regulation of potassium ion transport (GO:0043267) | 2.73125935 |
| 83 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.71956709 |
| 84 | heart process (GO:0003015) | 2.71466925 |
| 85 | heart contraction (GO:0060047) | 2.71466925 |
| 86 | tricarboxylic acid cycle (GO:0006099) | 2.69979263 |
| 87 | positive regulation of heart contraction (GO:0045823) | 2.68387943 |
| 88 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.68174609 |
| 89 | positive regulation of muscle hypertrophy (GO:0014742) | 2.68174609 |
| 90 | positive regulation of cation channel activity (GO:2001259) | 2.66447892 |
| 91 | regulation of action potential (GO:0098900) | 2.64344397 |
| 92 | positive regulation of ATPase activity (GO:0032781) | 2.63386124 |
| 93 | positive regulation of ATP catabolic process (GO:1903291) | 2.63386124 |
| 94 | striated muscle cell development (GO:0055002) | 2.61869619 |
| 95 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.60261106 |
| 96 | response to caffeine (GO:0031000) | 2.59587836 |
| 97 | axonal fasciculation (GO:0007413) | 2.59549319 |
| 98 | cardiac muscle tissue development (GO:0048738) | 2.56961741 |
| 99 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.56172144 |
| 100 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.56099133 |
| 101 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.55711771 |
| 102 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55387583 |
| 103 | cardiac right ventricle morphogenesis (GO:0003215) | 2.55140590 |
| 104 | adrenergic receptor signaling pathway (GO:0071875) | 2.54600688 |
| 105 | vocalization behavior (GO:0071625) | 2.54101901 |
| 106 | cardiac ventricle formation (GO:0003211) | 2.53694379 |
| 107 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.53672709 |
| 108 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.52663954 |
| 109 | dendritic spine morphogenesis (GO:0060997) | 2.52228673 |
| 110 | multicellular organismal signaling (GO:0035637) | 2.52007502 |
| 111 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.51695705 |
| 112 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.49680115 |
| 113 | relaxation of muscle (GO:0090075) | 2.49234377 |
| 114 | actin filament-based movement (GO:0030048) | 2.48755100 |
| 115 | ventricular cardiac muscle cell development (GO:0055015) | 2.46617057 |
| 116 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.46306511 |
| 117 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46003255 |
| 118 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.44025721 |
| 119 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.43504779 |
| 120 | fatty acid transmembrane transport (GO:1902001) | 2.43484517 |
| 121 | positive regulation of potassium ion transport (GO:0043268) | 2.42927308 |
| 122 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.42853249 |
| 123 | venous blood vessel morphogenesis (GO:0048845) | 2.42280900 |
| 124 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.41077028 |
| 125 | cell junction maintenance (GO:0034331) | 2.41023245 |
| 126 | membrane repolarization (GO:0086009) | 2.39859737 |
| 127 | regulation of cation channel activity (GO:2001257) | 2.38673615 |
| 128 | activation of protein kinase A activity (GO:0034199) | 2.38185108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.54200321 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.05315531 |
| 3 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.63313861 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.44539110 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34310080 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.14165669 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.11472835 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.11472835 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11252475 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.07444114 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06177497 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05433882 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99939642 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95158532 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.93301969 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.93099364 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92272577 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88843642 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87124899 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78553894 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77936615 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72253578 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.66469564 |
| 24 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65693690 |
| 25 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.64939668 |
| 26 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.61919727 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.61422216 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.61389432 |
| 29 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57298411 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56559060 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54998651 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54590618 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52709307 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52276507 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.47898602 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.46520454 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41794927 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41344926 |
| 39 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.40309124 |
| 40 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40143305 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39441997 |
| 42 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39238565 |
| 43 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.38903887 |
| 44 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.38274588 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.38056400 |
| 46 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37663489 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37342786 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37323889 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.36732438 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35809571 |
| 51 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35368013 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.34717849 |
| 53 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33986769 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32027745 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31921870 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31803010 |
| 57 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30858132 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.29452827 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.27687169 |
| 60 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.27312351 |
| 61 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25460153 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.24444102 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.23985132 |
| 64 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.23985132 |
| 65 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23249940 |
| 66 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22345698 |
| 67 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21555953 |
| 68 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21480176 |
| 69 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.21017869 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18638022 |
| 71 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.18474969 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.17996057 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17861693 |
| 74 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16803492 |
| 75 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16344695 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16122228 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16015445 |
| 78 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15134737 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14504731 |
| 80 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13910617 |
| 81 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12450013 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10813759 |
| 83 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09902215 |
| 84 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09755443 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.09423498 |
| 86 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09347431 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09330688 |
| 88 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08521498 |
| 89 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.07972447 |
| 90 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.07875259 |
| 91 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.07564514 |
| 92 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07217337 |
| 93 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06974753 |
| 94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06284940 |
| 95 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05867265 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05667752 |
| 97 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05224733 |
| 98 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05224733 |
| 99 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.04734510 |
| 100 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03413068 |
| 101 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02193682 |
| 102 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01158898 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98262753 |
| 104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98038625 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97188018 |
| 106 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96169444 |
| 107 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94333522 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93965247 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93965247 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93709049 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92814585 |
| 112 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92536214 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91575912 |
| 114 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89792203 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89170322 |
| 116 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88622588 |
| 117 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.87421203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.22801352 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.15966073 |
| 3 | MP0004215_abnormal_myocardial_fiber | 3.91095907 |
| 4 | MP0000751_myopathy | 3.52849216 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.11555535 |
| 6 | MP0005330_cardiomyopathy | 2.77588302 |
| 7 | MP0003137_abnormal_impulse_conducting | 2.59045653 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.55427853 |
| 9 | MP0002972_abnormal_cardiac_muscle | 2.54322006 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.52287995 |
| 11 | MP0000749_muscle_degeneration | 2.42354478 |
| 12 | MP0003646_muscle_fatigue | 2.38897888 |
| 13 | MP0004085_abnormal_heartbeat | 2.38016217 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.31759434 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.27435700 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.24860839 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.03285288 |
| 18 | MP0004484_altered_response_of | 1.94781498 |
| 19 | MP0006138_congestive_heart_failure | 1.93383854 |
| 20 | MP0003880_abnormal_central_pattern | 1.84385343 |
| 21 | MP0001544_abnormal_cardiovascular_syste | 1.83194004 |
| 22 | MP0005385_cardiovascular_system_phenoty | 1.83194004 |
| 23 | MP0010630_abnormal_cardiac_muscle | 1.81234214 |
| 24 | MP0002127_abnormal_cardiovascular_syste | 1.76903339 |
| 25 | MP0003635_abnormal_synaptic_transmissio | 1.71833905 |
| 26 | MP0004510_myositis | 1.69906351 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.69370732 |
| 28 | MP0004270_analgesia | 1.66156113 |
| 29 | MP0002106_abnormal_muscle_physiology | 1.58479659 |
| 30 | MP0002269_muscular_atrophy | 1.56044980 |
| 31 | MP0005670_abnormal_white_adipose | 1.54346151 |
| 32 | MP0003122_maternal_imprinting | 1.49681916 |
| 33 | MP0004233_abnormal_muscle_weight | 1.49351242 |
| 34 | MP0004130_abnormal_muscle_cell | 1.46826954 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.39123145 |
| 36 | MP0005369_muscle_phenotype | 1.39004540 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.38692826 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.35481279 |
| 39 | MP0000013_abnormal_adipose_tissue | 1.34340794 |
| 40 | MP0004272_abnormal_basement_membrane | 1.33789696 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.31292828 |
| 42 | MP0002822_catalepsy | 1.31245365 |
| 43 | MP0010368_abnormal_lymphatic_system | 1.30114293 |
| 44 | MP0009745_abnormal_behavioral_response | 1.29248844 |
| 45 | MP0003136_yellow_coat_color | 1.21111334 |
| 46 | MP0003828_pulmonary_edema | 1.20963271 |
| 47 | MP0005623_abnormal_meninges_morphology | 1.17824176 |
| 48 | MP0001486_abnormal_startle_reflex | 1.16182832 |
| 49 | MP0000566_synostosis | 1.15034953 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.14137444 |
| 51 | MP0001529_abnormal_vocalization | 1.13973491 |
| 52 | MP0000747_muscle_weakness | 1.13456512 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.11315851 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.10775199 |
| 55 | MP0003879_abnormal_hair_cell | 1.09968884 |
| 56 | MP0000759_abnormal_skeletal_muscle | 1.07780007 |
| 57 | MP0002064_seizures | 1.07531915 |
| 58 | MP0005551_abnormal_eye_electrophysiolog | 1.05958637 |
| 59 | MP0003787_abnormal_imprinting | 1.04811218 |
| 60 | MP0002734_abnormal_mechanical_nocicepti | 1.03659360 |
| 61 | MP0002102_abnormal_ear_morphology | 0.99664398 |
| 62 | MP0004043_abnormal_pH_regulation | 0.99371873 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.99089823 |
| 64 | MP0005253_abnormal_eye_physiology | 0.98945311 |
| 65 | MP0003283_abnormal_digestive_organ | 0.98849942 |
| 66 | MP0002272_abnormal_nervous_system | 0.97217743 |
| 67 | MP0009046_muscle_twitch | 0.96700293 |
| 68 | MP0002653_abnormal_ependyma_morphology | 0.93898414 |
| 69 | MP0005423_abnormal_somatic_nervous | 0.93551934 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.92640976 |
| 71 | MP0005646_abnormal_pituitary_gland | 0.92274406 |
| 72 | MP0000230_abnormal_systemic_arterial | 0.90859375 |
| 73 | MP0004133_heterotaxia | 0.90275208 |
| 74 | MP0004924_abnormal_behavior | 0.89126512 |
| 75 | MP0005386_behavior/neurological_phenoty | 0.89126512 |
| 76 | MP0002735_abnormal_chemical_nociception | 0.88986367 |
| 77 | MP0005187_abnormal_penis_morphology | 0.87528582 |
| 78 | MP0003252_abnormal_bile_duct | 0.85611447 |
| 79 | MP0001968_abnormal_touch/_nociception | 0.85266464 |
| 80 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83941885 |
| 81 | MP0000266_abnormal_heart_morphology | 0.83600263 |
| 82 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83419460 |
| 83 | MP0002067_abnormal_sensory_capabilities | 0.83305062 |
| 84 | MP0000778_abnormal_nervous_system | 0.83140069 |
| 85 | MP0003195_calcinosis | 0.82649882 |
| 86 | MP0003011_delayed_dark_adaptation | 0.81442714 |
| 87 | MP0000955_abnormal_spinal_cord | 0.80682476 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.80353870 |
| 89 | MP0002108_abnormal_muscle_morphology | 0.79932331 |
| 90 | MP0005085_abnormal_gallbladder_physiolo | 0.79576425 |
| 91 | MP0003045_fibrosis | 0.79070027 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.78921804 |
| 93 | MP0002184_abnormal_innervation | 0.78030151 |
| 94 | MP0004885_abnormal_endolymph | 0.77520333 |
| 95 | MP0001440_abnormal_grooming_behavior | 0.77481209 |
| 96 | MP0001485_abnormal_pinna_reflex | 0.75445492 |
| 97 | MP0001984_abnormal_olfaction | 0.75189027 |
| 98 | MP0005165_increased_susceptibility_to | 0.75044991 |
| 99 | MP0003950_abnormal_plasma_membrane | 0.72082861 |
| 100 | MP0002882_abnormal_neuron_morphology | 0.71580990 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.71126685 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.70799165 |
| 103 | MP0003937_abnormal_limbs/digits/tail_de | 0.68682273 |
| 104 | MP0001944_abnormal_pancreas_morphology | 0.68296587 |
| 105 | MP0008569_lethality_at_weaning | 0.68013003 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.67528464 |
| 107 | MP0002557_abnormal_social/conspecific_i | 0.67525922 |
| 108 | MP0002752_abnormal_somatic_nervous | 0.67431945 |
| 109 | MP0001879_abnormal_lymphatic_vessel | 0.66600784 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.65287989 |
| 111 | MP0000569_abnormal_digit_pigmentation | 0.64447830 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.64354404 |
| 113 | MP0005595_abnormal_vascular_smooth | 0.64093035 |
| 114 | MP0004142_abnormal_muscle_tone | 0.64025262 |
| 115 | MP0005365_abnormal_bile_salt | 0.63930119 |
| 116 | MP0000026_abnormal_inner_ear | 0.63683731 |
| 117 | MP0001502_abnormal_circadian_rhythm | 0.63128775 |
| 118 | MP0000462_abnormal_digestive_system | 0.61382511 |
| 119 | MP0003279_aneurysm | 0.61176687 |
| 120 | MP0002928_abnormal_bile_duct | 0.60587299 |
| 121 | MP0008004_abnormal_stomach_pH | 0.59805059 |
| 122 | MP0001970_abnormal_pain_threshold | 0.59597231 |
| 123 | MP0002090_abnormal_vision | 0.58996369 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.58912969 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.57958519 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.56853730 |
| 127 | MP0003633_abnormal_nervous_system | 0.55946177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.37711279 |
| 2 | Atrial fibrillation (HP:0005110) | 5.45370116 |
| 3 | Syncope (HP:0001279) | 5.24360826 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 5.10902502 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 4.89371131 |
| 6 | Supraventricular tachycardia (HP:0004755) | 4.81758181 |
| 7 | Ventricular tachycardia (HP:0004756) | 4.80045777 |
| 8 | Supraventricular arrhythmia (HP:0005115) | 4.75222405 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.58558836 |
| 10 | Prolonged QT interval (HP:0001657) | 4.50367476 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.45490091 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.15600537 |
| 13 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.12172759 |
| 14 | Subaortic stenosis (HP:0001682) | 4.12172759 |
| 15 | Ventricular arrhythmia (HP:0004308) | 3.90270099 |
| 16 | Lipoatrophy (HP:0100578) | 3.88275977 |
| 17 | Exercise-induced myalgia (HP:0003738) | 3.74800591 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.67707520 |
| 19 | Bundle branch block (HP:0011710) | 3.64297521 |
| 20 | Ventricular fibrillation (HP:0001663) | 3.52775581 |
| 21 | Exercise-induced muscle cramps (HP:0003710) | 3.43701354 |
| 22 | Abnormal EKG (HP:0003115) | 3.35833340 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.34092163 |
| 24 | Hyporeflexia of lower limbs (HP:0002600) | 3.33150822 |
| 25 | Focal motor seizures (HP:0011153) | 3.28222868 |
| 26 | Dilated cardiomyopathy (HP:0001644) | 3.24581359 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.21226562 |
| 28 | Palpitations (HP:0001962) | 3.14012592 |
| 29 | Heart block (HP:0012722) | 3.01495391 |
| 30 | Ketoacidosis (HP:0001993) | 2.95747662 |
| 31 | Atrioventricular block (HP:0001678) | 2.91099093 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 2.90701752 |
| 33 | Hypoplastic ischia (HP:0003175) | 2.80664375 |
| 34 | Abnormal atrioventricular conduction (HP:0005150) | 2.77367773 |
| 35 | Left ventricular hypertrophy (HP:0001712) | 2.77217092 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.70342132 |
| 37 | Hypoglycemic seizures (HP:0002173) | 2.69110036 |
| 38 | Myoglobinuria (HP:0002913) | 2.60571157 |
| 39 | Hyperglycemia (HP:0003074) | 2.56855953 |
| 40 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.54252048 |
| 41 | Abnormality of the ischium (HP:0003174) | 2.54150772 |
| 42 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.43379059 |
| 43 | Hyperventilation (HP:0002883) | 2.28324618 |
| 44 | Pheochromocytoma (HP:0002666) | 2.25986734 |
| 45 | Myotonia (HP:0002486) | 2.19972014 |
| 46 | Dysmetric saccades (HP:0000641) | 2.16661730 |
| 47 | Focal seizures (HP:0007359) | 2.16130073 |
| 48 | Epileptic encephalopathy (HP:0200134) | 2.12850754 |
| 49 | Central scotoma (HP:0000603) | 2.11050969 |
| 50 | Hypoplastic left heart (HP:0004383) | 2.06391296 |
| 51 | Bradycardia (HP:0001662) | 2.06008309 |
| 52 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.04965478 |
| 53 | Symptomatic seizures (HP:0011145) | 2.00191136 |
| 54 | Decreased circulating renin level (HP:0003351) | 1.98532663 |
| 55 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.94844046 |
| 56 | Steppage gait (HP:0003376) | 1.94285600 |
| 57 | Lymphangioma (HP:0100764) | 1.93608919 |
| 58 | Gait imbalance (HP:0002141) | 1.92806249 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 1.89907297 |
| 60 | Large for gestational age (HP:0001520) | 1.88862502 |
| 61 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88534424 |
| 62 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88534424 |
| 63 | Sudden cardiac death (HP:0001645) | 1.88185178 |
| 64 | Ketosis (HP:0001946) | 1.86611883 |
| 65 | Drooling (HP:0002307) | 1.85761291 |
| 66 | Palmoplantar keratoderma (HP:0000982) | 1.85117218 |
| 67 | Broad-based gait (HP:0002136) | 1.84205651 |
| 68 | Neuroendocrine neoplasm (HP:0100634) | 1.82926077 |
| 69 | Difficulty running (HP:0009046) | 1.81972109 |
| 70 | Rimmed vacuoles (HP:0003805) | 1.78310460 |
| 71 | Visual hallucinations (HP:0002367) | 1.78174411 |
| 72 | Atonic seizures (HP:0010819) | 1.76525764 |
| 73 | Progressive cerebellar ataxia (HP:0002073) | 1.76310909 |
| 74 | Agitation (HP:0000713) | 1.71804735 |
| 75 | Congenital primary aphakia (HP:0007707) | 1.70989851 |
| 76 | Late onset (HP:0003584) | 1.70551923 |
| 77 | Nephronophthisis (HP:0000090) | 1.69585111 |
| 78 | Abnormality of the aortic arch (HP:0012303) | 1.69543598 |
| 79 | Pancreatic fibrosis (HP:0100732) | 1.69247453 |
| 80 | True hermaphroditism (HP:0010459) | 1.69206124 |
| 81 | Limited hip movement (HP:0008800) | 1.69098239 |
| 82 | Myokymia (HP:0002411) | 1.68934291 |
| 83 | Increased connective tissue (HP:0009025) | 1.68238287 |
| 84 | Neoplasm of the adrenal gland (HP:0100631) | 1.68018074 |
| 85 | Abnormality of the foot musculature (HP:0001436) | 1.67768392 |
| 86 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67647055 |
| 87 | Hip contracture (HP:0003273) | 1.67539764 |
| 88 | Febrile seizures (HP:0002373) | 1.67283863 |
| 89 | Epileptiform EEG discharges (HP:0011182) | 1.67186078 |
| 90 | Skin nodule (HP:0200036) | 1.66498026 |
| 91 | Double outlet right ventricle (HP:0001719) | 1.66376659 |
| 92 | Congenital malformation of the right heart (HP:0011723) | 1.66376659 |
| 93 | Congestive heart failure (HP:0001635) | 1.66033896 |
| 94 | Patent foramen ovale (HP:0001655) | 1.65945073 |
| 95 | Poor eye contact (HP:0000817) | 1.64212848 |
| 96 | Generalized tonic-clonic seizures (HP:0002069) | 1.63756592 |
| 97 | EMG: neuropathic changes (HP:0003445) | 1.63624104 |
| 98 | Type 1 muscle fiber predominance (HP:0003803) | 1.63339831 |
| 99 | Vitreoretinal degeneration (HP:0000655) | 1.63179160 |
| 100 | Genital tract atresia (HP:0001827) | 1.61969089 |
| 101 | Hypoplastic heart (HP:0001961) | 1.61805986 |
| 102 | Abnormality of the pubic bones (HP:0003172) | 1.61538913 |
| 103 | Abnormality of the labia minora (HP:0012880) | 1.60806329 |
| 104 | EEG with generalized epileptiform discharges (HP:0011198) | 1.60228455 |
| 105 | Vaginal atresia (HP:0000148) | 1.59850843 |
| 106 | Excessive salivation (HP:0003781) | 1.59520890 |
| 107 | Lower limb amyotrophy (HP:0007210) | 1.58506416 |
| 108 | Anxiety (HP:0000739) | 1.58179608 |
| 109 | Neoplasm of the heart (HP:0100544) | 1.57591133 |
| 110 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.56634971 |
| 111 | Muscular dystrophy (HP:0003560) | 1.56318400 |
| 112 | Neck muscle weakness (HP:0000467) | 1.55152439 |
| 113 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.54798637 |
| 114 | Absence seizures (HP:0002121) | 1.53427761 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 1.53274681 |
| 116 | Distal lower limb amyotrophy (HP:0008944) | 1.53242386 |
| 117 | Difficulty climbing stairs (HP:0003551) | 1.52980075 |
| 118 | Scanning speech (HP:0002168) | 1.52548774 |
| 119 | Impaired social interactions (HP:0000735) | 1.52417404 |
| 120 | Abnormal social behavior (HP:0012433) | 1.52417404 |
| 121 | Nephrogenic diabetes insipidus (HP:0009806) | 1.52058445 |
| 122 | Pachygyria (HP:0001302) | 1.51499589 |
| 123 | Hepatoblastoma (HP:0002884) | 1.50425539 |
| 124 | Distal lower limb muscle weakness (HP:0009053) | 1.50128712 |
| 125 | Aneurysm (HP:0002617) | 1.49536332 |
| 126 | Labial hypoplasia (HP:0000066) | 1.48072700 |
| 127 | Abnormality of the renal medulla (HP:0100957) | 1.46584294 |
| 128 | Blue irides (HP:0000635) | 1.42561012 |
| 129 | Poor coordination (HP:0002370) | 1.42410778 |
| 130 | Exotropia (HP:0000577) | 1.42251282 |
| 131 | Abnormal pancreas size (HP:0012094) | 1.41129973 |
| 132 | Periauricular skin pits (HP:0100277) | 1.40940305 |
| 133 | Preauricular pit (HP:0004467) | 1.40940305 |
| 134 | Action tremor (HP:0002345) | 1.39979020 |
| 135 | Congenital sensorineural hearing impairment (HP:0008527) | 1.37479595 |
| 136 | Polyphagia (HP:0002591) | 1.36850395 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.35804857 |
| 138 | Pancreatic cysts (HP:0001737) | 1.34735076 |
| 139 | Maternal diabetes (HP:0009800) | 1.34674506 |
| 140 | Transposition of the great arteries (HP:0001669) | 1.33969704 |
| 141 | Abnormal connection of the cardiac segments (HP:0011545) | 1.33969704 |
| 142 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.33969704 |
| 143 | Occipital encephalocele (HP:0002085) | 1.32388346 |
| 144 | Hypsarrhythmia (HP:0002521) | 1.31411337 |
| 145 | Hemiparesis (HP:0001269) | 1.31286380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 3.40215941 |
| 2 | OBSCN | 3.35734160 |
| 3 | EPHA4 | 2.93687986 |
| 4 | MYLK | 2.82238404 |
| 5 | NTRK3 | 2.76220640 |
| 6 | DMPK | 2.65619597 |
| 7 | PHKG2 | 2.22587629 |
| 8 | PHKG1 | 2.22587629 |
| 9 | MAP4K2 | 2.15177847 |
| 10 | LMTK2 | 2.05172535 |
| 11 | MAP3K4 | 1.91790532 |
| 12 | TTN | 1.86928322 |
| 13 | PAK3 | 1.84146766 |
| 14 | PIK3CA | 1.78804759 |
| 15 | EPHA3 | 1.67235114 |
| 16 | CASK | 1.62137227 |
| 17 | AKT3 | 1.60876829 |
| 18 | CDC42BPA | 1.59122687 |
| 19 | STK24 | 1.47852425 |
| 20 | MAP2K7 | 1.46148716 |
| 21 | PRKD3 | 1.46052716 |
| 22 | WNK4 | 1.45908322 |
| 23 | MUSK | 1.41334603 |
| 24 | SIK1 | 1.37010230 |
| 25 | DAPK2 | 1.36567816 |
| 26 | CAMK2D | 1.35001775 |
| 27 | MARK1 | 1.31836627 |
| 28 | MAP2K4 | 1.27987543 |
| 29 | TIE1 | 1.26357181 |
| 30 | MAP3K9 | 1.26064946 |
| 31 | LIMK1 | 1.25033191 |
| 32 | LATS1 | 1.24854437 |
| 33 | KSR1 | 1.21715780 |
| 34 | PAK6 | 1.20158181 |
| 35 | PNCK | 1.19504848 |
| 36 | PTK2B | 1.19279915 |
| 37 | CAMK2A | 1.18249615 |
| 38 | PKN2 | 1.17117983 |
| 39 | STK38 | 1.11171258 |
| 40 | ZAK | 1.10944043 |
| 41 | PDK3 | 1.10273657 |
| 42 | PDK4 | 1.10273657 |
| 43 | FER | 1.08131737 |
| 44 | FRK | 1.05528349 |
| 45 | DYRK2 | 1.05429398 |
| 46 | ROCK1 | 1.03571086 |
| 47 | CAMK1 | 1.01671507 |
| 48 | SGK2 | 1.01641861 |
| 49 | PRKCE | 1.00299161 |
| 50 | RIPK1 | 0.97836653 |
| 51 | PLK2 | 0.95539785 |
| 52 | STK38L | 0.92145855 |
| 53 | PDGFRA | 0.90384945 |
| 54 | UHMK1 | 0.86955418 |
| 55 | PRKD1 | 0.85540869 |
| 56 | BMPR1B | 0.83439379 |
| 57 | MINK1 | 0.82759031 |
| 58 | SGK223 | 0.82727608 |
| 59 | SGK494 | 0.82727608 |
| 60 | NTRK2 | 0.82627027 |
| 61 | STK11 | 0.80313407 |
| 62 | PINK1 | 0.80112031 |
| 63 | CAMK2B | 0.80000790 |
| 64 | CDK5 | 0.79491747 |
| 65 | KSR2 | 0.78097559 |
| 66 | PRKAA1 | 0.77787174 |
| 67 | CAMK1G | 0.77518851 |
| 68 | FGFR2 | 0.77340400 |
| 69 | MAPK13 | 0.77189280 |
| 70 | MAP3K6 | 0.77072806 |
| 71 | EPHB2 | 0.76794701 |
| 72 | CAMK4 | 0.76128791 |
| 73 | NTRK1 | 0.75978254 |
| 74 | DDR2 | 0.75851627 |
| 75 | SGK3 | 0.75714884 |
| 76 | ERBB3 | 0.75220143 |
| 77 | WNK1 | 0.74714135 |
| 78 | MAP3K7 | 0.74371731 |
| 79 | BCR | 0.73781270 |
| 80 | MAP3K2 | 0.72977768 |
| 81 | CAMKK1 | 0.72506273 |
| 82 | MARK2 | 0.72437285 |
| 83 | SGK1 | 0.70299044 |
| 84 | CAMKK2 | 0.69298696 |
| 85 | MAPK12 | 0.69177527 |
| 86 | TRIB3 | 0.68161191 |
| 87 | PRKAA2 | 0.66964386 |
| 88 | RET | 0.66920265 |
| 89 | PTK2 | 0.66207431 |
| 90 | MAP3K5 | 0.64162367 |
| 91 | PDK2 | 0.63743975 |
| 92 | FLT3 | 0.63220806 |
| 93 | DAPK3 | 0.63106447 |
| 94 | CAMK1D | 0.59010851 |
| 95 | NUAK1 | 0.59001408 |
| 96 | DYRK1A | 0.58880880 |
| 97 | MAP3K12 | 0.57060185 |
| 98 | CAMK2G | 0.56899115 |
| 99 | STK39 | 0.55710302 |
| 100 | PRKCH | 0.55413252 |
| 101 | STK3 | 0.55290794 |
| 102 | GRK1 | 0.53049690 |
| 103 | NLK | 0.51842474 |
| 104 | ILK | 0.51297212 |
| 105 | DYRK1B | 0.50732489 |
| 106 | TNIK | 0.50710169 |
| 107 | WNK3 | 0.50042631 |
| 108 | CSNK1G2 | 0.49617003 |
| 109 | PRKACG | 0.49493034 |
| 110 | PRKCG | 0.49490681 |
| 111 | PRKACA | 0.49097851 |
| 112 | ROCK2 | 0.48835463 |
| 113 | TRIM28 | 0.47064879 |
| 114 | MAPKAPK3 | 0.46691874 |
| 115 | MAPK15 | 0.45816049 |
| 116 | SIK3 | 0.44928471 |
| 117 | PKN1 | 0.44562155 |
| 118 | MAP2K1 | 0.44341203 |
| 119 | NEK9 | 0.44164026 |
| 120 | PRKCZ | 0.43382491 |
| 121 | GRK7 | 0.43081625 |
| 122 | PRKG1 | 0.42652484 |
| 123 | TRPM7 | 0.42333786 |
| 124 | DAPK1 | 0.41943351 |
| 125 | PRKACB | 0.41206562 |
| 126 | RPS6KA3 | 0.40819274 |
| 127 | DYRK3 | 0.39340471 |
| 128 | OXSR1 | 0.37173336 |
| 129 | CSNK1G1 | 0.37170668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.98532979 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.73492612 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.64312509 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.58244081 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.28252496 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.13659129 |
| 7 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02326235 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 1.90166712 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.88469178 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86070928 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.72270902 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.64926561 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.61093060 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.54128540 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53267008 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.52929905 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49852827 |
| 18 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.48384385 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.46245534 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45447255 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.43206630 |
| 22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.42211194 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.41194986 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41131898 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.32112261 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32068714 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.31679971 |
| 28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.29318954 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24560890 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.22800679 |
| 31 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.19641415 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.18795697 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17953659 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17668650 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17473380 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16561624 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15053712 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.09481180 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.08741661 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08407807 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06233231 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04543147 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.04313128 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03165556 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02256696 |
| 46 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99519839 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99113043 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 0.96007451 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94078205 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.93714819 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88733846 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88193355 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 0.87569965 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87534686 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.86871599 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86408718 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85864131 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85138424 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84848496 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83507652 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83375660 |
| 62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82159312 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.81674257 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.81594991 |
| 65 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81481650 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80823803 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.80401040 |
| 68 | Melanogenesis_Homo sapiens_hsa04916 | 0.80241917 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.79937762 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79374991 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77971655 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.76759106 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.76298592 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76148877 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75822076 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.75316783 |
| 77 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74650719 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74644289 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73380744 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.73122740 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.72901250 |
| 82 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.72742747 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72046781 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.71981808 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71328880 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.70605557 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.69280196 |
| 88 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67813880 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65348355 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64408964 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.63727312 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63427912 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63228817 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62636249 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.62148418 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61747253 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61405180 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.61294264 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61038865 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59666531 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.59609411 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59319002 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58470685 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56499431 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56385158 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55830246 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.55717211 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51210728 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50185540 |
| 110 | Glioma_Homo sapiens_hsa05214 | 0.49903867 |
| 111 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49810809 |
| 112 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49185610 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49152633 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49152177 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49055435 |
| 116 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49015455 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48886970 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47578835 |
| 119 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47537117 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47533052 |
| 121 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47309452 |
| 122 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46633801 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45824914 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.44137099 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43718199 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40675519 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40244995 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40010011 |
| 129 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39921679 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39854556 |

